Fluticasone Propionate Nasal Spray USP
CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex
Yes — there is an active recall. 3 ongoing FDA recalls mention Fluticasone (22 total). Check the affected lots below.
Most common reason: Wrong potency / content (5 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Fluticasone. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex
CGMP Deviations: potential presence of Burkholderia cepacia complex
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Defective container: defect prevents product from dispensing as intended.
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Defective Container: Potential for broken glass in the neck area of the glass bottles.
Presence of foreign substance: Potential for glass in the neck area of the glass bottles.
Presence of foreign substance: glass particles
CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
Failed Stability Specifications: Out of specification for preservative, benazalkonium chloride.
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.
Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.